IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 12234 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
Mitra Niafar,Leili Pourafkari,Kavus Shahsavarinia,Nushin Milanchian,Farhad Niafar,Nader Nader
Journal of Cardiovascular and Thoracic Research.2016;8(1)8
2Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus
Jessica L Kerr,Erin M Timpe,Katherine A Petkewicz
Annals of Pharmacotherapy.2010;44(11)1777
3A Systematic Account of Pathogenesis, Diagnosis and Pharmacotherapy of Metabolic Syndrome: Things We Need to Know
R. Mahajan,K. Gupta,V. Kapoor
International Journal of Pharmacology.2010;6(4)338
4The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Kira V. Derkach,Vera M. Bondareva,Oxana V. Chistyakova,Lev M. Berstein,Alexander O. Shpakov
International Journal of Endocrinology.2015;2015(4)1
5The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Patricio Atanes,Shanta J. Persaud
International Journal of Endocrinology.2020;2015(4)367
6The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes
K. V. Derkach,V. M. Bondareva,I. V. Moiseyuk,A. O. Shpakov
Cell and Tissue Biology.2015;9(5)395
7Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA.2015;1(3)395
8Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I
Lev M Vieira,Lev M Souto,Lev M Sánchez-López,Lev M Machado,Lev M Severino,Lev M Jose,Lev M Santini,Lev M Fortuna,Lev M García,Lev M Silva,Lev M Souto
9Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel
S. Kalra,S. Ghosh,A.K. Das,T. Nair,S. Bajaj,G. Priya,R.N. Mehrotra,S. Das,P. Shah,V. Deshmukh,M. Chawla,D. Sanyal,S. Chandrasekaran,D. Khandelwal,A. Joshi,F. Eliana,H. Permana,M.D. Fariduddin,P.K. Shrestha,D. Shrestha,S. Kahandawa,M. Sumanathilaka,A. Shaheed,A.A. Rahim,A. Orabi,A. Al-ani,W. Hussein,D. Kumar,K. Shaikh
Indian Heart Journal.2020;72(1)7
10Therapeutic Approaches for Zika Virus Infection of the Nervous System
Rachel P. M. Abrams,Jamie Solis,Avindra Nath
11Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
Alfredo Briones-Aranda,Javier Ramírez-Carballo,Bernardo Alfredo Romero Gómez,Victor Manuel Vega Villa,Manuela Castellanos Pérez,Esmeralda Garcia Parra,Hugo Roberto Santeliz-Montero
Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2018;25(1)59
12Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
Mohammed Fouad Shalaby,Hekma A. Abd El Latif,Mohamed El Yamani,May Ahmed Galal,Sherifa Kamal,Ikhlas Sindi
Current Therapeutic Research.2021;95(1)100647
13Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations
Oscar L. Morey-Vargas,Ali Aminian,Karen Steckner,Keren Zhou,Sangeeta R. Kashyap,Derrick Cetin,Kevin M. Pantalone,Christopher Daigle,Marcio L. Griebeler,W. Scott Butsch,Robert Zimmerman,Matthew Kroh,Hussein F. Saadi,Danielle Diemer,Bartolome Burguera,Raul J. Rosenthal,M. Cecilia Lansang
Surgery for Obesity and Related Diseases.2022;18(8)1087
14Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis
Beyene Dereje,Aschalew Nardos
Journal of Diabetes & Metabolic Disorders.2023;18(8)1087
15Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo
Yuan Li,Haifeng Zhang,Weihong Long,Menghan Gao,Weiying Guo,Lu Yu
16Circadian rhythms and pancreas physiology: A review
Karl Chan,F. Susan Wong,James Alexander Pearson
Frontiers in Endocrinology.2022;13(21)8745
17Antihyperglycemic, Antihyperlipidemic and Cardioprotective Profile of Bromocriptine, Glibenclamide and Metformin Combination in Dexamethasone-induced Hyperglycemic Rats
Adejuwon Adewale Adeneye,Joseph Abayomi Olagunju
18Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
Zachary J. Farino,Travis J. Morgenstern,Julie Vallaghe,Nathalie Gregor,Prashant Donthamsetti,Paul E. Harris,Nicolas Pierre,Robin Freyberg,Fabienne Charrier-Savournin,Jonathan A. Javitch,Zachary Freyberg,Faramarz Dehghani
PLOS ONE.2016;11(2)e0148684
19Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
Kyriaki Savva,Margarita Zachariou,Anastasis Oulas,George Minadakis,Kleitos Sokratous,Nikolas Dietis,George M. Spyrou
PLOS ONE.2019;11(2)85
20Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus
Md. Tanvir Kabir,Jannatul Ferdous Mitu,Raushanara Akter,Muhammad Furqan Akhtar,Ammara Saleem,Ahmed Al-Harrasi,Saurabh Bhatia,Md. Sohanur Rahman,Fouad Damiri,Mohammed Berrada,Md. Habibur Rahman
Environmental Science and Pollution Research.2022;29(31)46385
21Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Elisabetta Esposito,Paolo Mariani,Laura Ravani,Catia Contado,Mattia Volta,Simone Bido,Markus Drechsler,Serena Mazzoni,Enea Menegatti,Michele Morari,Rita Cortesi
European Journal of Pharmaceutics and Biopharmaceutics.2012;80(2)306
22Bromocriptine therapy: Review of mechanism of action, safety and tolerability
Faiza Naz,Abdul Malik,Muhammad Riaz,Qaisar Mahmood,Malik Hassan Mehmood,Ghulam Rasool,Zahed Mahmood,Mazhar Abbas
Clinical and Experimental Pharmacology and Physiology.2022;49(8)903
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow